
2023 AbbVie
Golden Ticket
Apply by October 25, 2023

AbbVie and BioLabs Heidelberg invite you to apply for a Golden Ticket. The Golden Ticket provides lab bench and office space for one year, and access to the AbbVie team of scientific and industry advisors.
The Benefits

Access to fully permitted shared lab space

Unparalleled suite of laboratory
equipment

A diverse community of entrepreneurs and industry leaders

On/off site content rich events and programming
Eligibility Snapshot
AbbVie is looking for early-stage biotech companies that fit the following criteria
Focused on science / technology with the potential to generate transformational therapies in one of the below stated therapeutic areas
Developing therapeutic platform technologies, including gene therapy, novel cell therapy, gene editing, or novel drug-discovery or platform technologies
Companies must not have a significant partnership with another large biopharmaceutical company
However, current, or prior recipients of similar awards sponsored by other pharmaceutical companies or lab spaces are eligible to apply
Companies must have their principal place of business in the Heidelberg area or be willing to relocate to Heidelberg
Therapeutic Areas at a Glance


The Application Process
01
Submit applications by
October 25, 2023
11:59 CET
02
A subset of applicants will be identified as finalists by the contest judges by
November 4, 2023
03
Finalists will present their company & scientific concept at a live event on
November 9, 2023
04
Golden Ticket winner to enter the Biolabs lab space between
December 2023
and
February 2024

Application Process
The official application process can be found above. Please read and verify your availability before submitting your application.


Application Form
The official application form for this competition should be submitted via our application form. Make sure to fill out the form completely before submitting it.


Slide Deck
You must prepare and submit a compelling non-confidential pitch deck that gives an overview of your company and technology. Please be sure to submit through our application form.

Contact Us
